aprindine has been researched along with Chronic Illness in 4 studies
Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A placebo-controlled, randomized, double-blind, crossover study was performed in 14 patients with chronic, resistant, ventricular arrhythmias in order to evaluate the efficacy and safety of two new antiarrhythmic agents, propafenone and aprindine." | 9.05 | [Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo]. ( Amici, R; Ciampani, N; Costantini, C; Mocchegiani, R; Pigini, G; Purcaro, A, 1983) |
| "A placebo-controlled, randomized, double-blind, crossover study was performed in 14 patients with chronic, resistant, ventricular arrhythmias in order to evaluate the efficacy and safety of two new antiarrhythmic agents, propafenone and aprindine." | 5.05 | [Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo]. ( Amici, R; Ciampani, N; Costantini, C; Mocchegiani, R; Pigini, G; Purcaro, A, 1983) |
| "The efficacy of disopyramide (DP), mexiletine (MX), aprindine (AP) and cibenzoline (CZ) on ventricular arrhythmias was compared (single drug therapy)." | 3.67 | Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias. ( Furuya, H; Goto, Y; Tanabe, T; Yoshikawa, H, 1988) |
| "The object of this study was to compare the efficacity and the side effects of Aprindine and Quinidine in patients with stable ventricular arrhythmias." | 3.66 | [Comparison of the efficacy of aprindine and quinidine in chronic ventricular rhythm disorders]. ( Attuel, P; Coumel, P; Leclercq, JF; Milosevic, D; Rosengarten, MD, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Purcaro, A | 1 |
| Amici, R | 1 |
| Ciampani, N | 1 |
| Costantini, C | 1 |
| Mocchegiani, R | 1 |
| Pigini, G | 1 |
| Leclercq, JF | 1 |
| Attuel, P | 1 |
| Milosevic, D | 1 |
| Rosengarten, MD | 1 |
| Coumel, P | 1 |
| Oyama, Y | 1 |
| Kanda, K | 1 |
| Kawasaki, H | 1 |
| Tanabe, T | 1 |
| Yoshikawa, H | 1 |
| Furuya, H | 1 |
| Goto, Y | 1 |
1 trial available for aprindine and Chronic Illness
| Article | Year |
|---|---|
[Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo].
Topics: Adult; Aged; Aprindine; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Double-Blin | 1983 |
3 other studies available for aprindine and Chronic Illness
| Article | Year |
|---|---|
[Comparison of the efficacy of aprindine and quinidine in chronic ventricular rhythm disorders].
Topics: Aprindine; Arrhythmias, Cardiac; Chronic Disease; Heart Ventricles; Humans; Indenes; Quinidine | 1981 |
[Aprindine in the treatment of chronic premature ventricular contractions. Evaluations based on the two-way analysis of variance and linear regression analysis].
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Aprindine; Cardiac Complexes, Premature; Ch | 1986 |
Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Chronic Disease; Disopyramide; | 1988 |